| dc.contributor.author | RAVI, NARAYANASAMY | en |
| dc.date.accessioned | 2017-02-21T14:37:54Z | |
| dc.date.available | 2017-02-21T14:37:54Z | |
| dc.date.issued | 2016 | en |
| dc.date.submitted | 2016 | en |
| dc.identifier.citation | Phoa K.N, Rosmolen W.D, Weusten B.L.A.M, Bisschops R, Schoon E.J, Das S, Ragunath K, Fullarton G, DiPietro M, Ravi N, Tijssen J.G.P, Dijkgraaf M.G.W, Bergman J.J.G.H.M, The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: Results from a randomized controlled trial (SURF trial), Gastrointestinal Endoscopy, 2016, 1-- | en |
| dc.identifier.other | Y | en |
| dc.description | IN_PRESS | en |
| dc.description.abstract | Background and Aims
The Surveillance versus Radiofrequency Ablation (SURF) trial randomized 136 patients with Barrett's esophagus (BE) containing low-grade dysplasia (LGD), to receive radiofrequency ablation (ablation, n = 68) or endoscopic surveillance (control, n = 68). Ablation reduced the risk of neoplastic progression to high-grade dysplasia and esophageal adenocarcinoma (EAC) by 25% over 3 years (1.5% for ablation vs 26.5% for control). We performed a cost-effectiveness analysis from a provider perspective alongside this trial. | en |
| dc.description.sponsorship | J.J.G.H.M.B., B.L.A.M.W., R.B., E.J.S., and M.D.P. have received funding from Covidien GI Solutions for Institutional Review Board approved study protocols and have received a speaker’s fee for participation in postgraduate courses. J.J.G.H.M.B. has received funding from Covidien GI Solutions for the development of training programs and postgraduate courses. G.F. has received funding from Covidien GI Solutions for Joint Advisory Group approved therapeutic endoscopy courses. K.R. has received a speaker’s fee, educational grants, and consultancy fees from Covidien GI Solutions. All other authors disclosed no financial relationships relevant to this publication. The SURF study was supported, in part, by Covidien GI Solutions, Sunnyvale, CA, USA, and by a grant from the Dutch Digestive Diseases Foundation (MLDS grant: WO 07-60). | en |
| dc.format.extent | 1- | en |
| dc.relation.ispartofseries | Gastrointestinal Endoscopy | en |
| dc.rights | Y | en |
| dc.subject | Surveillance versus Radiofrequency Ablation (SURF) trial | en |
| dc.subject.lcsh | Surveillance versus Radiofrequency Ablation (SURF) trial | en |
| dc.title | The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: Results from a randomized controlled trial (SURF trial) | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/ravin | en |
| dc.identifier.rssinternalid | 152242 | en |
| dc.identifier.doi | http://dx.doi.org/10.1016/j.gie.2016.12.001 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.rssuri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011547334&doi=10.1016%2fj.gie.2016.12.001&partnerID=40&md5=967210edd20ef72a611c1c48ff400c06 | en |
| dc.identifier.uri | http://hdl.handle.net/2262/79445 | |
